What is the price of pomalidomide in 2025?

Pomalidomide is an important immunomodulator mainly used to treat multiple myeloma. This drug is particularly suitable for patients whose disease has not responded to treatment with lenalidomide or a proteasome inhibitor, or whose disease has progressed within 60 days of the last treatment. Pomalidomide exerts anti-tumor effects by interfering with the growth and proliferation of tumor cells and enhancing the function of the immune system.

Pomalidomide usually comes in the form of capsules, and the recommended dose is 4 mg per day, taken for 21 days in a 28-day treatment cycle, followed by 7 days off to form a complete treatment cycle. This medication may be combined with corticosteroids such as dexamethasone to enhance its effectiveness.

However, the use of pomalidomide may also be associated with a range of side effects. Common side effects include fatigue, nausea, diarrhea, constipation, back pain, bone pain, muscle pain, headache, dizziness, etc. In addition, pomalidomide may also have effects on the blood system, leading to neutropenia, anemia, and thrombocytopenia. The severity and frequency of these side effects vary from individual to individual, so patients need to closely monitor their physical condition while receiving pomalidomide and undergo individualized treatment under the guidance of a physician.

Overall, pomalidomide, as an effective anti-tumor drug, provides a new treatment option for patients with multiple myeloma. However, patients also need to pay attention to potential side effects and risks when using it, and use it rationally under the guidance of a doctor.

Pomalidomide has been launched in China and has been included in the medical insurance reimbursement items.The reimbursed price of 4mg*21 tablets is about 5,000 yuan. The specific reimbursement ratio varies by region, so you need to consult the local medical insurance reimbursement department. In overseas markets, the price of generic drugs of the same specifications is lower, about 650 yuan from ASEAN Pharmaceuticals in Laos and about 2,200 yuan from NATCO in India. If you need to know more about pomalidomide, please consult a regular overseas medical consulting agency.

xa0

Reference materials:https://www.drugs.com/mtm/pomalidomide.html